Seres Therapeutics | 8-K: Current report
Seres Therapeutics | 8-K: Current report
Seres Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Graves Kurt
Seres Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Biondi Paul
Seres Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Fraser Claire
Seres Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Ausiello Dennis A
Seres Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Berenson Stephen
Seres Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Kender Richard N
Seres Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Dere Willard H
Seres Therapeutics | DEFA14A: Others
Seres Therapeutics | DEF 14A: Definitive information statements
Seres Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Seres Therapeutics | 10-K: FY2024 Annual Report
Seres Therapeutics | 8-K: SERES THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATES
Seres Therapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Seres Therapeutics | 8-K: Current report
Seres Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Young Teresa L.
Seres Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Henn Matthew R.
Seres Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Shaff Eric D.
Seres Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer DesRosier Thomas